open access

Vol 59, No 6 (2008)
Original papers
Published online: 2008-10-30
Submitted: 2013-02-15
Get Citation

Receptor CD36 expression on peripheral blood monocytes in women with visceral obesity

Justyna Kuliczkowska-Płaksej, Grażyna Bednarek-Tupikowska, Alicja Filus
Endokrynologia Polska 2008;59(6):483-489.

open access

Vol 59, No 6 (2008)
Original papers
Published online: 2008-10-30
Submitted: 2013-02-15

Abstract


Introduction: Receptor CD36 is involved in foam cells formation and in atherogenesis. Visceral obesity is important risk factor of accelerated atherosclerosis. There are no data about the role of CD36 in pathogenesis of atherosclerosis in women with visceral obesity. The aim of the study was to assess the impact of visceral obesity on CD36 expression on peripheral blood monocytes.
Material and methods: CD36 expression was evaluated (by flow cytometry) in study population consisted of 30 women aged 25-45 years (mean 34.03 ± 11.14) with visceral obesity. Control group consisted of 15 nonobese women aged 25-45 years (mean 31.93 ± 2.43). Physical examination was performed with body mass, BMI, waist and hip circumferences, waist to hip ratio evaluation. Oral glucose tolerance test was performed with estimation of glucose and insulin concentrations.
Results: Body mass, BMI, WHR, waist and hip circumferences were significantly higher in obese than in nonobese women. Glucose and insulin concentrations in 0’, 30’ 60’ of OGTT as well as HOMA and FIRI values were significantly higher in obese than in nonobese women. Expression of CD36 on monocytes was significantly lower in obese women (mean 62.99 ± 18.07) than in controls (mean 82.5 ± 22.93). There were not significant correlations between CD36 expression and BMI, WHR and IR indexes.
Conclusions: Expression of scavenger receptor CD36 on monocytes in obese women is significantly lower than in lean individuals. This observation needs further investigations.

Abstract


Introduction: Receptor CD36 is involved in foam cells formation and in atherogenesis. Visceral obesity is important risk factor of accelerated atherosclerosis. There are no data about the role of CD36 in pathogenesis of atherosclerosis in women with visceral obesity. The aim of the study was to assess the impact of visceral obesity on CD36 expression on peripheral blood monocytes.
Material and methods: CD36 expression was evaluated (by flow cytometry) in study population consisted of 30 women aged 25-45 years (mean 34.03 ± 11.14) with visceral obesity. Control group consisted of 15 nonobese women aged 25-45 years (mean 31.93 ± 2.43). Physical examination was performed with body mass, BMI, waist and hip circumferences, waist to hip ratio evaluation. Oral glucose tolerance test was performed with estimation of glucose and insulin concentrations.
Results: Body mass, BMI, WHR, waist and hip circumferences were significantly higher in obese than in nonobese women. Glucose and insulin concentrations in 0’, 30’ 60’ of OGTT as well as HOMA and FIRI values were significantly higher in obese than in nonobese women. Expression of CD36 on monocytes was significantly lower in obese women (mean 62.99 ± 18.07) than in controls (mean 82.5 ± 22.93). There were not significant correlations between CD36 expression and BMI, WHR and IR indexes.
Conclusions: Expression of scavenger receptor CD36 on monocytes in obese women is significantly lower than in lean individuals. This observation needs further investigations.
Get Citation

Keywords

scavenger receptor CD36; atherosclerosis; visceral obesity

About this article
Title

Receptor CD36 expression on peripheral blood monocytes in women with visceral obesity

Journal

Endokrynologia Polska

Issue

Vol 59, No 6 (2008)

Pages

483-489

Published online

2008-10-30

Bibliographic record

Endokrynologia Polska 2008;59(6):483-489.

Keywords

scavenger receptor CD36
atherosclerosis
visceral obesity

Authors

Justyna Kuliczkowska-Płaksej
Grażyna Bednarek-Tupikowska
Alicja Filus

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl